Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Diabetes and the cardiovascular risk challenge - mechanisms, epidemiology and treatment aspects

The Berzelius symposia are the most prestigious scientific meetings organised by the Swedish Society for Medicine (SSM), this time in collaboration with Lunds Universitet (LU) and Karolinska Institutet (KI). The symposium will focus on mechanisms and clinical aspects of the relationship between diabetes and cardiovascular disease in the light of new studies and trial data that expand our understanding of this relationship and new treatment possibilities. An abstract book and proceedings will be published. The conference is open to all clinicians and basic science representatives from the Nordic area, international guests and lecturers, as well as representatives from pharma and device manufacturers. We hope that you will join us for the Berzelius symposium on 23–25th May 2018 and look forward to your active participation. There will be a number of oral presentations but also a possibility to submit abstracts for poster presentation.

Preliminary program


For updated program, please see SLS webb

Wednesday May 23rd


Registration at Jubileumsaulan, Malmö


Opening of symposium

Stefan Lindgren, President, the Swedish Society of Medicine

Jan Nilsson, Chail of the sceintific board, HLF Foundation

Mona Landin-Olsson, President SFD, Lund

Peter M Nilsson, Chair, Organizing committee, Malmö

Session 1: Definition of diabetes and origins of cardiovascular complications
Chair: Lena Jonasson, Linköping

13:10-13:30 Diabetes - a disease with many faces. Leif Groop, Malmö, SE

13:30-13:50 Lifestyle interventions in the context of precision medicine. Paul Franks, Malmö, SE

13:50-14:10 The red blood cell in diabetes. John Pernow, Stockholm, SE

14:10-14:30 The gene-diet-microbiota-metabolism link. Marju Orho-Melander, Malmö, SE

14:30-15:00 Coffee

Session 2: Epidemiology and trends
Chair: Annika Rosengren, Gothenburg

15:00-15:20 Life course perspectives. The Finnish experience. Johan Eriksson, Helsinki, FI

15:20-15:40 Early life porgramming of cardiometabolic disease - Global perspectives. Chittaranjan Yajjnik, Pune, India

15:40-16:00 Global trends in diabets and prediabetes - A threatening scenario. William Knowler, Phoenix, US

16:00-16:20 Global trends in cardiovascular disease - increased disease burden, but not everywhere. Helena Nordenstedt, Stockholm, SE

Session 3: State-of-the-Art I
Chair: Leif Groop, Malmö

16:20-16:50 Personalized medicine to treat patients with diabetes. Andrew Hattersley, Exeter, UK

16:50-17:00 Best poster abstract I

19:00 Welcome Reception at Malmö Town Hall ("Rådhus") hosted by the Malmö City Council

Thursday May 24th

Session 4: Diabetes - the clinical spectrum
Chair: Anna Norhammar, Stockholm

08:30-08:50 Micro- and macrovascular complications. John Petrie, Glasgow, UK

08:50-09:10 Glucose variability and CVD. Antonio Ceriello, Milano, IT

09:10-09:30 Risk factors, omics and the heart in diabetes. Martin Magnusson, Malmö, SE

09:30-09:50 Endocrine disturbances in diabetes and cardiovascular diseases. Olle Melander, Malmö, SE

09:50-10:20 Coffee

Session 5: State-of-the-Art II
Chair: Marju Orho-Melander, Malmö, SE.

10:20-10:50 Lifestyle as the first step for prevention and treatment of diabetes. Maj-Lis Hellenius, Stockholm, SE

Session 6: Primary prevention of CVD complications in diabetes
Chair: Peter Rossing, Copenhagen, DK

10:50-11:10 Glycaemic control. Katarina Eeg-Olofsson, Gothenburg, SE

11:10-11:30 Lipid control. Mats Eriksson, Stockholm, SE

11:30-11:50 Blood pressure control. Karin Manhem, Gothenburg, SE

11:50-12:10 Cardio-renal protection. Per-Henrik Groop, Helsinki, FI


12:10-13:00 Lunch, Posters

Session 7: Secondary prevention of CVD complications in diabetes
Chair: Linda Mellbin, Stockholm

13:00-13:20 The importance of a target driven multifactorial approach. Lars Rydén, Stockholm, SE

13:20-13:40 New lipid-lowering treatment and goals. Olov Wiklund, Gothenburg, SE

13:40-14:00 Arterial stiffness - A new treatment target? Peter M Nilsson, Malmö, SE

Pro-Pro debate

14:00-14:40 Second-line treatment for type 2 diabetes - incretin active drugs or SGLT2 inhibitors as first choice?!

Pro incretin drugs: Jens Juul Holst, Copenhagen, DK

Pro SGLT2 drugs: Jan Eriksson, Uppsala, SE

14:40-15:10 Coffee, Posters

Session 8: The role of guidelines for prevention of cardiovascular compications
Chair: Lars Rydén, Stockholm, SE

15:10-15:30 European perspective. Francesco Cosentino, Stockholm, SE

15:30-15:50 Transatlantic perspective. William M Herman, US

15:50-16:10 Swedish perspective. Carl Johan Östergren, Linköping, SE

Session 9: State-of-the-Art 3
Chair: Martin Ridderstråle

16:10-16:40 Integration of basic and clinical science for prevenion of diabetes complications - focus on the incretin system. Eberhard Standl, DE

16:40-17:00 Best poster abstract 2 and 3

19:00 Symposium Dinner at the Scandic Triangeln in Malmö. Pre-registration is necessary.

Friday May 25th

Session 10: Quality Assessment and Developments, Registers
Chair: Emil Hagström, Uppsala, SE

08:30-08:50 The National Diabetes Register, Sweden. Soffia Gudbjörnsdottir, Gothenburg, SE

08:50-09:10 SWEDEHEART, Sweden. Tomas Jernberg, Stockholm, SE

09:10-09:30 SEPHIA Register, Sweden. Margrét Leosdottir, Malmö, SE

09:30-09:50 EUROSPIRE. Viveca Gyberg, Stockholm, SE


09:50-10:20 Coffee, Posters

Session 11: The role of Patients, Relatives and the Health Care Organisation
Chair: Mona Landin-Olsson, Lund, SE

10:20-10:40 Swedish Diabetes Association. Fredrik Löndahl, Helsingborg, SE

10:40-11:00 Patient centered health care. Åsa Hörnsten, Umeå, SE

11:00-11:20 Primary Health Care. Carl Johan Östgren, Linköping, SE

11:20-11:40 The Steno Diabetes Centre Concept. Allan Flyvbjerg, Copenhagen, DK

Panel debate: Quality of diabetes care - New challenges for 2020!
Chair: Anders Frid, Malmö, SE

11:40-12:30 Panelists: Karin Wikblad, Fredrik Löndahl, Carl Johan Östgren, Allan Flyvbjerg, Soffia Gudbjörnsdottir, Viveca Gyberg, Stig Attvall.

12:30-12:40 Closing remarks. Lars Rydén and Peter M Nilsson


You are most welcome to submit a poster abtract to the meeting. Please register for the meeting before you send in the abstract. Max length 44 lines with Times New Roman 12 p.

A limited number of abstracts will be selected for an oral pressentation n the poster sessions.
Please send your abstract to annie [dot] melin [at] sls [dot] se no later than 15 April, 2018.
Poster boards at the meeting: approx size of 90 cm wide x 120 cm.
If you already have a poster in larger size, two boards can be used.


23 May 2018 13:00 to 25 May 2018 12:45
Jubilee aula, MFC, Jan Waldenströms gata 1, SUS Malmö
camilla.key [at]

About the event

23 May 2018 13:00 to 25 May 2018 12:45
Jubilee aula, MFC, Jan Waldenströms gata 1, SUS Malmö
camilla.key [at]

Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00